Compass Pathways Stock (NASDAQ: CMPS) stock price, news, charts, stock research, profile.
Open | $7.08 |
Close | $7.12 |
Volume / Avg. | 366.28K / 410.13K |
Day Range | 6.80 - 7.21 |
52 Wk Range | 5.01 - 12.75 |
Market Cap | $488.92M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 61 |
Short Interest | 7.52% |
Days to Cover | 13.87 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Compass Pathways (NASDAQ:CMPS) through any online brokerage.
Other companies in Compass Pathways’s space includes: Cabaletta Bio (NASDAQ:CABA), Valneva (NASDAQ:VALN), Precigen (NASDAQ:PGEN), Voyager Therapeutics (NASDAQ:VYGR) and Korro Bio (NASDAQ:KRRO).
There is no analysis for Compass Pathways.
Compass Pathways has a consensus price target of $42.00.
The stock price for Compass Pathways (NASDAQ: CMPS) is $7.15 last updated July 15, 2024 at 6:15 PM EDT.
There are no upcoming dividends for Compass Pathways.
Compass Pathways’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Compass Pathways.
Compass Pathways is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.